NCT01782235View on ClinicalTrials.gov

Efficacy of Tocilizumab in Primary Sjögren's Syndrome.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

July 24, 2013

Primary Completion Date

July 16, 2018

Study Completion Date

July 16, 2018

Conditions
Primary Sjögren's Syndrome (pSS)
Interventions
DRUG

Tocilizumab

DRUG

Placebo

Trial Locations (1)

67098

Hôpitaux Universitaires de Strasbourg, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT01782235 - Efficacy of Tocilizumab in Primary Sjögren's Syndrome. | Biotech Hunter | Biotech Hunter